FDA Approves Device for Diagnosing, Treating Prostate Cancer

The FDA recently approved a new medical device for prostate biopsies and improving the accuracy of less-invasive cancer treatments. Created by St. Louis-based Envisioneering Medical Technologies, TargetScan is the latest innovation in prostate mapping, biopsy and cancer treatment guidance.

ArriveNet (http://press.arrivenet.com/pro/article.php/597984.html)